{"id":1409,"date":"2026-09-26T09:15:28","date_gmt":"2026-09-26T01:15:28","guid":{"rendered":"http:\/\/www.puriactives.com\/en\/?p=1409"},"modified":"2026-09-26T09:15:28","modified_gmt":"2026-09-26T01:15:28","slug":"oleaxin-oleanolic-acid-nanogel","status":"publish","type":"post","link":"http:\/\/www.puriactives.com\/en\/?p=1409","title":{"rendered":"OleaXin™ Oleanolic Acid Nanogel"},"content":{"rendered":"

 <\/p>\n

<\/p>\n

PURIPHARM CO., LTD. \u00b7 PuriActives\u00ae High-Performance Actives<\/p>\n

OleaXin™ Oleanolic Acid Nanogel<\/h2>\n

\u9f50\u80a4\u56e0™ \u00b7 Oleanolic Acid Nanogel<\/p>\n

From a high-potential pentacyclic triterpene to a modern Nanogel active system.<\/p>\n

INCI: Oleanolic Acid \u00b7 Phospholipids \u00b7 Glycerin \u00b7 Water<\/p>\n

Technical Marketing Presentation \u00b7 For B2B Professional Use Only<\/p>\n

01 \u00b7 THE OPPORTUNITY<\/p>\n

Why Refocus on Oleanolic Acid?<\/h2>\n

01 A Multi-Target Biological Foundation<\/h3>\n

Sebum regulation \u00b7 inflammatory signaling \u00b7 oxidative stress \u00b7 ECM homeostasis \u00b7 follicular microenvironment. Oleanolic acid is a pentacyclic triterpene widely found in olive, Ligustrum lucidum, and other plants, long followed by dermatological literature. Its value lies not in a single benefit, but in simultaneously touching multiple biological pathways related to oily skin, blemish-prone skin, and scalp health.<\/p>\n

02 Skin + Scalp Dual Scenarios<\/h3>\n

Facial oil control and soothing share one mechanistic framework with scalp oil management.<\/p>\n

03 A Deep Literature and Patent Base<\/h3>\n

From enzymology and cell studies to animal and human research, the evidence chain spans more than two decades.<\/p>\n

04 Aligned with Oily-Skin and Scalp-Care Trends<\/h3>\n

Blemish-prone skin management, scalp microbiome care, and the \u201cskinification\u201d of hair care continue to gain momentum.<\/p>\n

The scientific potential is high, yet formulation use is anything but simple \u2014 its highly lipophilic molecular nature has kept oleanolic acid a \u201cresearch hotspot\u201d rather than a \u201cformulation regular.\u201d<\/p>\n

02 \u00b7 MOLECULAR IDENTITY<\/p>\n

Meet Oleanolic Acid: A Classic Pentacyclic Triterpene<\/h2>\n

Naming note: <\/b>\u201c\u77f3\u7af9\u7d20\u201d is the Chinese inventory name of Oleanolic Acid in China’s cosmetic ingredient system; the scientific narrative uses \u201c\u9f50\u58a9\u679c\u9178\u201d (oleanolic acid), the name familiar to R&D professionals. Official ingredient information follows the INCI name.<\/p>\n

<\/p>\n\n\n\n\n\n\n\n\n\n
INCI name<\/td>\nOleanolic Acid<\/td>\n<\/tr>\n
Chinese inventory name<\/td>\n\u77f3\u7af9\u7d20 (Inventory of Existing Cosmetic Ingredients in China)<\/td>\n<\/tr>\n
CAS number<\/td>\n508-02-1<\/td>\n<\/tr>\n
Formula \/ MW<\/td>\nC\u2083\u2080H\u2084\u2088O\u2083 \/ 456.70 g\u00b7mol\u207b\u00b9<\/td>\n<\/tr>\n
Chemical class<\/td>\nPentacyclic triterpene (\u03b2-amyrin type)<\/td>\n<\/tr>\n
Natural sources<\/td>\nOlive leaves, Ligustrum lucidum, Centella asiatica, and other plants<\/td>\n<\/tr>\n
Physicochemical profile<\/td>\nHighly lipophilic; practically insoluble in water<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

A molecule studied for over half a century \u2014 as one of the active components of many medicinal plants, its anti-inflammatory, antioxidant, and metabolism-modulating activities have been repeatedly reported in pharmacological literature, and its skin and scalp biology value continues to be rediscovered.<\/p>\n

References: Ayeleso TB et al. Molecules. 2017;22(11):1915. DOI:10.3390\/molecules22111915; PubChem CID 10494.<\/p>\n

03 \u00b7 THE FORMULATION CHALLENGE<\/p>\n

High Bioactivity Does Not Mean High Formulation Usability<\/h2>\n

<\/p>\n

Practical Impact for Formulators<\/h3>\n

Difficult to dose directly into water-based serums and gels, requiring pre-dissolving or solubilization design; crystallization causes non-uniform content, affecting batch stability and efficacy consistency; high-ethanol \/ high-oil solubilization limits sensory feel and dosage-form options; the active’s theoretical efficacy is hard to convert reliably into finished-product performance.<\/p>\n

The Industry Recognized This Long Ago<\/h3>\n

As early as 2001, an international cosmetics group filed a patent around \u201csolubilizing pentacyclic triterpenic acids\u201d (US 2001\/0029266 A1), improving dispersion through specific emulsifier systems. Review literature likewise notes that oleanolic acid’s low water solubility limits its bioavailability, with structural modification and delivery systems as the two solution paths.<\/p>\n

Solving the formulation bottleneck matters more than discovering yet another benefit \u2014 this is exactly where OleaXin™ starts.<\/p>\n

References: US 2001\/0029266 A1; Wang W et al. Curr Top Med Chem. 2022;22(1). DOI:10.2174\/1568026621666211105101231.<\/p>\n

04 \u00b7 THE SOLUTION<\/p>\n

PuriActives\u00ae OleaXin™ \u2014 Rebuilding Oleanolic Acid as a Nanogel<\/h2>\n

OleaXin™ converts highly lipophilic oleanolic acid, through phospholipid association and nanostructured dispersion, into a Nanogel active format compatible with aqueous systems \u2014 without changing the molecule itself, only the way it exists in a formula.<\/p>\n\n\n\n
INCI NAMEOleanolic Acid \u77f3\u7af9\u7d20Phospholipids \u78f7\u8102 \u00b7 Glycerin \u7518\u6cb9 \u00b7 Water \u6c34<\/td>\nDESIGN LOGICOleanolic acid + phospholipids + glycerin + water\u2192 Nanogel Delivery System<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n
a. Nanostructured deliveryNanostructured presentation of a lipophilic active<\/td>\nb. Aqueous compatibilityAqueous-compatible format for modern chassis<\/td>\n<\/tr>\n
c. Formulation-friendly dispersionImproved dispersion, fewer pre-dissolving steps<\/td>\nd. Skin & scalp versatilityOne active for both skin and scalp care<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u9f50\u80a4\u56e0™ is the Chinese product name of PuriActives\u00ae OleaXin™. This material is for cosmetic ingredient technical exchange only and involves no pharmaceutical claims.<\/p>\n

05 \u00b7 DELIVERY ENGINEERING<\/p>\n

From Crystalline Active to Nanogel: An Engineered Pathway<\/h2>\n

<\/p>\n

What It Means at the Formulation Level<\/h3>\n

\u00b7 Improved aqueous dispersion\u3000\u00b7 Lower crystallization risk\u3000\u00b7 Simpler pre-dissolving\u3000\u00b7 Broader dosage-form options\u3000\u00b7 Better formula uniformity<\/p>\n

Core conversion logic: <\/b>Hard-to-Formulate Bioactive \u2014\u2014\u2192 Ready-to-Use Advanced Active<\/p>\n

Technical note: this page illustrates the delivery system design principle. OleaXin™’s specific particle size, encapsulation efficiency, and penetration data are subject to measured values in the PuriPharm TDS; without cited measured data, this material does not use statements such as \u201cpenetration increased by XX%.\u201d<\/p>\n

06 \u00b7 BIOLOGICAL LANDSCAPE<\/p>\n

One Active, Multiple Skin and Scalp Biology Pathways<\/h2>\n

<\/p>\n

The pentacyclic triterpene scaffold determines oleanolic acid’s potential to interact with multiple cellular signaling pathways. The following chapters unfold in the order of mechanism \u2192 data \u2192 biological significance \u2192 cosmetic value<\/b>, each pathway annotated with traceable literature or patent evidence and its evidence level.<\/p>\n

07 \u00b7 SEBUM REGULATION<\/p>\n

Oil Balance: Starting from Sebaceous Gland Biology<\/h2>\n

<\/p>\n

Sebum secretion is governed by androgen signaling: testosterone is converted by 5\u03b1-reductase into the more potent DHT, driving sebaceous gland hyperplasia and lipid synthesis. 5\u03b1-reductase is therefore a classic target for oil-control actives.<\/b><\/p>\n

<\/p>\n

Human Efficacy Reference: An Oleanolic Acid-Containing Blend<\/h3>\n

28-day half-face controlled use test (3% blend, n\u224820, oily-skin panel); multi-ingredient system, not attributable to oleanolic acid alone.<\/p>\n\n\n\n
-21.7%skin gloss (mean)<\/td>\n-16%pore surface area (mean)<\/td>\n-32%sebum flow (mean)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Reading the Evidence<\/h3>\n

\u00b7 Oleanolic acid’s 5\u03b1-reductase inhibition is direct in-vitro enzymatic evidence<\/b> (patent assay data);\u00b7 The human data come from a multi-ingredient blend containing oleanolic acid, indicating the mechanism’s market translation value;\u00b7 Sebum management should also address inflammation and oxidative stress (next page).<\/p>\n

Data sources: US 7,182,963 B2 (in-vitro 5\u03b1-reductase enzymatic assay); attached technical documentation (28-day human test of an oleanolic acid-containing blend).<\/p>\n

08 \u00b7 BLEMISH-PRONE SKIN<\/p>\n

Blemish-Prone Skin Is Not a Single-Pathway Problem<\/h2>\n

Blemish formation involves the interplay of excess sebum, abnormal follicular duct keratinization, the microbial environment, and inflammatory responses. Oleanolic acid’s value lies in evidence covering several of these links \u2014 not merely \u201cantibacterial anti-acne.\u201d<\/p>\n\n\n\n
\u2460 Sebum secretion5\u03b1-reductase \/ androgen-driven lipid synthesis<\/td>\n\u2461 Follicular environmentDuct keratinization and sebum retention form the comedone microenvironment<\/td>\n\u2462 Microbial factorsCutibacterium acnes-related flora environment<\/td>\n\u2463 Inflammatory responseNF-\u03baB-driven redness and discomfort<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Where Oleanolic Acid’s Evidence Sits in Each Link<\/h3>\n

\u25a0 Sebum link<\/b>\u3000Concentration-dependent 5\u03b1-reductase inhibition (56.3% at 0.1%, in-vitro enzymatic assay)\u25a0 Microbial link<\/b>\u3000Patent literature reports inhibitory activity against C. acnes and other skin-related flora\u25a0 Inflammation link<\/b>\u3000Modulates NF-\u03baB \/ STAT1 signaling in keratinocytes and animal models (detailed next page)\u25a0 Barrier link<\/b>\u3000Promotes epidermal differentiation and barrier recovery, helping blemish-prone skin maintain a more stable state<\/p>\n

Translated into Cosmetic Language<\/h3>\n

\u00b7 Oily and blemish-prone skin care\u3000\u00b7 Sebum balance management\u3000\u00b7 Pore oil-environment management\u3000\u00b7 Soothing discomfort of blemish-prone skinNo pharmaceutical claims such as \u201ctreating acne\u201d; mechanistic evidence supports the product’s scientific narrative.<\/p>\n

References: US 7,182,963 B2; Kang YM et al. Int J Mol Sci. 2021;22:12000; Lim SW et al. J Dermatol. 2007;34:625-634.<\/p>\n

09 \u00b7 INFLAMMATORY BALANCE<\/p>\n

Stabilizing Stressed Skin from the Source of Inflammatory Signaling<\/h2>\n

<\/p>\n

Mechanistic Evidence: Cell and Animal Levels Corroborate Each Other<\/h3>\n

In vitro (HaCaT keratinocytes)<\/b>\u3000Under TNF-\u03b1 \/ IFN-\u03b3 stimulation, oleanolic acid blocked the activation of Akt, NF-\u03baB, and STAT1, and suppressed Th2-type cytokine and chemokine expression.<\/p>\n

In vivo (DNCB mouse model)<\/b>\u3000Three weeks of topical dosing significantly relieved dermatitis-like lesions, reducing epidermal\/dermal thickness, mast cell infiltration, and serum histamine levels.<\/p>\n

Cosmetic value<\/b>\u3000Helps soothe irritated skin \u00b7 Maintains a healthy inflammatory balance \u00b7 Improves skin comfort under stressful environments<\/p>\n

Data source: Kang YM et al. Int J Mol Sci. 2021;22(21):12000. DOI:10.3390\/ijms222112000 (animal and cell evidence, not human clinical conclusions).<\/p>\n

10 \u00b7 OXIDATIVE STRESS DEFENSE<\/p>\n

Helping Skin Build Stronger Stress Defense<\/h2>\n

An Honest Scientific Positioning: It Is Not a Classic \u201cAntioxidant\u201d<\/h3>\n

DPPH radical-scavenging assays show oleanolic acid’s direct scavenging capacity is weak (only 9.2% at 100 \u00b5M, roughly equivalent to 4.45 \u00b5M Trolox). Its value lies in another path: pharmacological research links the oleanolic acid scaffold to the Keap1 \/ Nrf2 endogenous defense system and downstream antioxidant enzymes (HO-1, NQO-1), and it reduces oxidative stress markers in inflammation models.<\/p>\n

<\/p>\n

Cell Compatibility: Evidence in Human Skin Fibroblasts<\/h3>\n

24-hour cytotoxicity assay: oleanolic acid (OA) showed no cytotoxicity up to 100 \u00b5M; its isomer ursolic acid (UA) had an IC\u2085\u2080 of 47.5 \u00b5M (MTT). OA is the gentler triterpene choice.<\/p>\n

Cosmetic value<\/b>\u3000Supports the cell’s endogenous defense against environmental stress \u00b7 Helps maintain a more stable skin state<\/p>\n

Data sources: W\u00f3jciak-Kosior M et al. Folia Histochem Cytobiol. 2011;49(4):664-669. DOI:10.5603\/FHC.2011.0050; Wang W et al. Curr Top Med Chem. 2022;22(1).<\/p>\n

11 \u00b7 EPIDERMAL HOMEOSTASIS<\/p>\n

Epidermal Homeostasis: Experimental Evidence for Barrier Resilience<\/h2>\n

<\/p>\n

Mechanistic Landing Point: PPAR-\u03b1 and Epidermal Differentiation Markers<\/h3>\n

In HaCaT keratinocytes, oleanolic acid (10 \u00b5mol\/L, 24 h) raised PPAR-\u03b1, involucrin, loricrin, and filaggrin protein expression to about 2\u00d7 control; electron microscopy showed increased lamellar body secretion and more complete lipid bilayer formation.<\/p>\n

Cosmetic value<\/b>\u3000Supports epidermal homeostasis and barrier resilience \u00b7 Helps maintain healthy skin barrier function \u00b7 Completes the oily-skin care logic together with oil control and soothing<\/p>\n

Data source: Lim SW et al. J Dermatol. 2007;34(8):625-634. DOI:10.1111\/j.1346-8138.2007.00344.x (animal and cell evidence).<\/p>\n

12 \u00b7 MATRIX PROTECTION<\/p>\n

Guarding the ECM: From Oxidative Stress to Collagen Degradation<\/h2>\n

<\/p>\n

\u25b2 Oleanolic acid’s known evidence sits at upstream nodes: modulating oxidative stress and inflammatory signaling (NF-\u03baB \/ MAPK family), influencing the matrix degradation cascade from its source.<\/p>\n

ECM-Related Evidence Leads<\/h3>\n

\u25a0 Delivery + collagen patent<\/b>\u3000An oleanolic acid liposome composition patent (CN 103221028 B) targets collagen production, showing that \u201cdelivery technology + ECM\u201d is an industry-recognized R&D path\u25a0 Photoaging use patent<\/b>\u3000A composition patent for pentacyclic triterpenic acids in preventing photoaging and sensitive skin (US 2001\/0029266 A1)\u25a0 Mechanistic level<\/b>\u3000MAPK \/ NF-\u03baB modulation evidence (see the inflammation chapter) covers upstream MMP signaling<\/p>\n

Evidence Boundary Statement<\/h3>\n

Current ECM-related evidence for oleanolic acid consists mainly of patents and mechanistic studies<\/b>; human anti-wrinkle clinical data are still lacking. This material therefore avoids statements like \u201creduces wrinkles by XX%\u201d and instead positions oleanolic acid as an upstream modulator of the oxidative stress \u2013 inflammation \u2013 matrix degradation cascade<\/b>.<\/p>\n

Cosmetic value<\/b>\u3000Supports ECM homeostasis \u00b7 Helps reduce stress-induced matrix degradation \u00b7 Maintains a collagen-rich skin structure \u00b7 Supports skin elasticity and firmness<\/p>\n

References: CN 103221028 B; US 2001\/0029266 A1; Kang YM et al. Int J Mol Sci. 2021;22:12000 (patent- and mechanism-level evidence).<\/p>\n

<\/p>\n

PART II \u00b7 SCALP SCIENCE<\/p>\n

Skin biology doesn\u2019t stop at the hairline.<\/h2>\n

From skin to scalp \u2014 shared sebum, inflammation, and oxidative stress biology.<\/p>\n

The scalp is an extension of the skin: dense sebaceous glands, dense follicles, and androgen sensitivity. The mechanistic evidence for oleanolic acid in facial sebum management applies equally to the scalp scenario.<\/p>\n

13 \u00b7 SCALP & ANDROGEN BIOLOGY<\/p>\n

Scalp Oil and Androgen Biology: Same Target, Second Scenario<\/h2>\n

<\/p>\n

Recalling the page-8 data: oleanolic acid concentration-dependently inhibits 5\u03b1-reductase in vitro (56.3% inhibition at 0.1%, US 7,182,963 B2) \u2014 a mechanism pointing to both facial sebum<\/b> and scalp oil<\/b> scenarios.<\/p>\n

What Makes the Scalp Scenario Special<\/h3>\n

\u00b7 High sebaceous gland density: oil oxidation products and flora metabolites together form an irritation source\u00b7 Follicles are sensitive to androgen signaling; DHT-related follicular microenvironment stress is a focus of hair-care research\u00b7 Scalp care is shifting from \u201chair-fiber cosmetic finish\u201d to \u201cscalp ecology management\u201d<\/p>\n

Compliant Cosmetic Language<\/h3>\n

\u00b7 Helps maintain a healthy scalp oil environment\u3000\u00b7 Supports scalp ecological balance\u3000\u00b7 Helps maintain a healthy follicular microenvironment\u3000\u00b7 Supports scalp and follicle vitalityNo \u201canti-hair-loss \/ hair-growth \/ hair-loss treatment\u201d claims.<\/p>\n

References: US 7,182,963 B2; WO 2017\/021247 A1 (hair-care composition patent containing oleanolic acid blends).<\/p>\n

14 \u00b7 FOLLICULAR MICROENVIRONMENT<\/p>\n

The Follicular Microenvironment: More Than Just \u201cOil Control\u201d<\/h2>\n

A 6-month open human study (56 subjects with androgenetic alopecia and telogen effluvium) showed that a scalp lotion containing oleanolic acid, apigenin, biotinyl tripeptide-1, and other ingredients significantly increased total hair count and anagen hair count. Oleanolic acid plays the 5\u03b1-reductase-modulating role in the blend.<\/p>\n

Dermatologist Assessment (D180, full sample)<\/h3>\n\n\n\n
35.7%hair felt denser and fuller<\/td>\n37.5%overall hair appearance improved<\/td>\n39.3%scalp coverage improved<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/p>\n

Reading the Evidence<\/h3>\n

\u00b7 Human data from a multi-ingredient blend cannot be attributed to oleanolic acid alone;\u00b7 Yet it is directionally consistent with the in-vitro 5\u03b1-reductase evidence, forming a \u201cmechanism + clinical signal\u201d combination;\u00b7 No adverse events were reported throughout, with favorable usability ratings.<\/p>\n

Cosmetic narrative: <\/b>balanced scalp oil \u2192 a healthier follicular environment \u2192 support for hair vitality. Focus on \u201cscalp care,\u201d not \u201chair-loss treatment.\u201d<\/p>\n

Data source: Garre A et al. J Cosmo Trichol. 2018;4(1):1000132. DOI:10.4172\/2471-9323.1000132 (multi-ingredient blend, 6-month open study).<\/p>\n

15 \u00b7 WHY NANOGEL MATTERS<\/p>\n

Why Does Nanogel Matter So Much for Oleanolic Acid?<\/h2>\n\n\n\n\n\n\n\n\n
Conventional Oleanolic Acid (Crystalline Raw Material)<\/th>\nPuriActives\u00ae OleaXin™ (Nanogel Active System)<\/th>\n<\/tr>\n
Poor compatibility with aqueous systems<\/td>\nAqueous-compatible Nanogel format<\/td>\n<\/tr>\n
Hard to disperse; requires pre-dissolving \/ solubilization design<\/td>\nImproved dispersion; more direct dosing<\/td>\n<\/tr>\n
Crystallization \/ precipitation risk<\/td>\nNanostructured presentation lowers recrystallization tendency<\/td>\n<\/tr>\n
Limited dosage-form and formulation freedom<\/td>\nGreater formulation flexibility (serum \/ gel \/ emulsion \/ scalp essence)<\/td>\n<\/tr>\n
A conventional active format<\/td>\nA delivery-enabled active for modern formulations<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Each comparison dimension corresponds to verifiable technical basis: oleanolic acid’s lipophilicity and solubilization difficulty are documented in literature and patents (US 2001\/0029266 A1; Wang et al. 2022); Nanogel-side statements describe delivery system design characteristics, with specific parameters subject to measured values in the PuriPharm TDS.<\/p>\n

16 \u00b7 FORMULATOR VALUE<\/p>\n

What Does It Mean for Formulators?<\/h2>\n
    \n
  • A more convenient way to use oleanolic acid<\/b>\u3000No need to solve solubilization from scratch; the active is dosed directly in water-dispersible form<\/li>\n
  • Greater formulation freedom<\/b>\u3000Less reliance on high-ethanol or high-oil solubilization<\/li>\n
  • Compatible with modern water-based serum systems<\/b>\u3000Works in serums, gels, emulsions, and other mainstream formats<\/li>\n
  • Skin Care + Scalp Care dual scenarios<\/b>\u3000One active covers both facial and scalp product lines<\/li>\n
  • Fewer complex pre-dissolving steps<\/b>\u3000Shorter process chain and lower batch-to-batch content-variation risk<\/li>\n
  • An easy nano-technology product story<\/b>\u3000The Nanogel delivery narrative combines scientific credibility with market recognition<\/li>\n
  • Supports lightweight dosage forms<\/b>\u3000Matches the \u201cfresh, non-greasy feel\u201d brief of oily-skin care<\/li>\n<\/ul>\n

    Hard-to-Formulate Bioactive \u2192 Ready-to-Use Advanced Active<\/p>\n

    17 \u00b7 APPLICATIONS \u2014 SKIN CARE<\/p>\n

    Skincare Applications: Every Direction Has a Biological Basis<\/h2>\n\n\n\n\n\n\n\n\n\n
    Sebum balance serum<\/td>\n5\u03b1-reductase modulation acting on upstream sebum-signaling (in-vitro enzymatic evidence)<\/td>\n<\/tr>\n
    Blemish-care serum<\/td>\nMulti-link support across sebum + microbial environment + inflammatory signaling (in-vitro \/ animal evidence)<\/td>\n<\/tr>\n
    Lightweight oil-control moisturizer<\/td>\nAqueous-compatible Nanogel format suits fresh, light-feel systems (delivery system design feature)<\/td>\n<\/tr>\n
    Soothing serum<\/td>\nNF-\u03baB \/ STAT1 inflammatory-signal modulation improves comfort under stress (animal + cell evidence)<\/td>\n<\/tr>\n
    Antioxidant defense serum<\/td>\nSupports endogenous defense pathways rather than relying on direct radical scavenging (mechanism-level evidence)<\/td>\n<\/tr>\n
    Anti-aging direction serum<\/td>\nUpstream modulation of the oxidative stress \u2013 inflammation \u2013 matrix degradation cascade (patent and mechanistic evidence)<\/td>\n<\/tr>\n
    Urban stress protection<\/td>\nDual oxidative + inflammatory stress management for UV \/ pollution scenarios (mechanism-level evidence)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    Application directions are development suggestions; specific efficacy claims must be based on finished-formula efficacy evaluations; evidence levels are annotated in each row.<\/p>\n

    18 \u00b7 APPLICATIONS \u2014 SCALP CARE<\/p>\n

    Scalp-Care Applications: A Scalp-First Formulation Mindset<\/h2>\n

    From \u201csmoothing the hair fiber\u201d to managing scalp ecology \u2014 this is the upgrade direction the scalp-care category is undergoing.<\/p>\n\n\n\n\n\n\n\n\n
    Scalp balance serum<\/td>\nScalp sebum modulation and oil-environment management (supported by in-vitro 5\u03b1-reductase evidence)<\/td>\n<\/tr>\n
    Oil-control scalp serum<\/td>\nA fresh, water-based-compatible formula for oily scalps<\/td>\n<\/tr>\n
    Leave-on scalp lotion<\/td>\nA leave-on format covering follicular microenvironment management<\/td>\n<\/tr>\n
    Soothing scalp care<\/td>\nInflammatory-signal modulation to help relieve scalp discomfort (animal + cell evidence)<\/td>\n<\/tr>\n
    Hair vitality essence<\/td>\nFollicular microenvironment + oxidative stress management supporting a healthy hair-growth environment (multi-ingredient clinical signal)<\/td>\n<\/tr>\n
    Anti-grease scalp care<\/td>\nDaily management of scalp oil oxidation and the flora environment<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    Compliance note: scalp applications focus on \u201cscalp care\u201d and the \u201chair vitality environment\u201d; no anti-hair-loss, hair-growth, or hair-loss-treatment claims; multi-ingredient human study data serve only as directional mechanistic reference.<\/p>\n

    19 \u00b7 CONCEPT SHOWCASE<\/p>\n

    Product Concept Examples<\/h2>\n

    OleaXin™ Sebum Reset Serum<\/h3>\n

    Sebum regulation + inflammatory balance + oxidative defense \u2014 a daily management serum for oily skin<\/p>\n

    OleaXin™ Clear Balance Essence<\/h3>\n

    Environment management for blemish-prone skin: sebum balance + microbial environment + soothing<\/p>\n

    OleaXin™ Matrix Defense Serum<\/h3>\n

    Upstream defense against oxidative stress and the matrix degradation cascade \u2014 anti-aging direction<\/p>\n

    OleaXin™ Scalp Balance Serum<\/h3>\n

    A scalp-balancing serum covering scalp sebum + soothing + follicular microenvironment<\/p>\n

    OleaXin™ Follicular Vitality Essence<\/h3>\n

    A leave-on scalp essence for oxidative stress + follicular environment + scalp vitality<\/p>\n

    Concept Design Principles<\/h3>\n

    \u00b7 Each concept maps to a defined combination of biological targets, not a pile-up of claims;\u00b7 Concepts are development-direction examples only and contain no experimentally unverified formula ratios;\u00b7 For use levels, compatibility, and stability data, refer to the PuriPharm TDS and formulation guide;\u00b7 Finished-product efficacy claims are subject to the final product’s efficacy evaluation.<\/p>\n

    20 \u00b7 VALUE SUMMARY<\/p>\n

    OleaXin™ Core Value: Three Pillars<\/h2>\n\n\n\n\n
    PILLAR IMultifunctional Biology<\/th>\nPILLAR IIAdvanced Delivery<\/th>\nPILLAR IIIFormulation Value<\/th>\n<\/tr>\n
    Sebum regulation \u00b7 inflammatory balanceOxidative stress defense \u00b7 ECM protectionEpidermal homeostasis \u00b7 scalp homeostasisA multi-target evidence chain, from in-vitro enzymology to human study signals<\/td>\nPhospholipid Nanogel delivery systemNanostructured presentationAqueous-system compatibilityChanging how the active exists in a formula, not the molecule itself<\/td>\nFlexible formats \u00b7 easy dosingSkin & scalp dual-scenario coverageA nano-technology product narrativeFrom hard-to-formulate bioactive to ready-to-use advanced active<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    Bringing the scientific potential of oleanolic acid into modern formulations.<\/b>UNLOCKING THE COSMETIC POTENTIAL OF OLEANOLIC ACID<\/p>\n

    21 \u00b7 SELECTED REFERENCES<\/p>\n

    Key References and Patents<\/h2>\n

    Peer-Reviewed Papers<\/h3>\n

    [1] Kang YM, Kim HM, Lee M, An HJ. Oleanolic Acid Alleviates Atopic Dermatitis-like Responses In Vivo and In Vitro. Int J Mol Sci. 2021;22(21):12000. DOI:10.3390\/ijms222112000[2] Lim SW, Hong SP, Jeong SW, et al. Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via PPAR-\u03b1. J Dermatol. 2007;34(8):625-634. DOI:10.1111\/j.1346-8138.2007.00344.x[3] W\u00f3jciak-Kosior M, Paduch R, Matysik-Wo\u017aniak A, et al. The effect of ursolic and oleanolic acids on human skin fibroblast cells. Folia Histochem Cytobiol. 2011;49(4):664-669. DOI:10.5603\/FHC.2011.0050[4] Garre A, Piquero J, Trullas C, Martinez G. Efficacy and Safety of a New Topical Hair Loss-Lotion Containing Oleanolic Acid, Apigenin, Biotinyl Tripeptide-1, Diaminopyrimidine Oxide, Adenosine, Biotin and Ginkgo biloba. J Cosmo Trichol. 2018;4(1):1000132. DOI:10.4172\/2471-9323.1000132 (multi-ingredient blend)[5] Ayeleso TB, Matumba MG, Mukwevho E. Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases. Molecules. 2017;22(11):1915. DOI:10.3390\/molecules22111915[6] Wang W, Li Y, Li Y, et al. Oleanolic Acid: Structural Modification and Biological Activities. Curr Top Med Chem. 2022;22(1). DOI:10.2174\/1568026621666211105101231<\/p>\n

    Patents and Technical Documentation<\/h3>\n

    [7] US 7,182,963 B2. Cosmetic and dermopharmaceutical compositions for skin prone to acne (contains in-vitro 5\u03b1-reductase enzymatic data for oleanolic acid; family: US 2006\/0239957 A1)[8] US 2001\/0029266 A1. Composition containing a pentacyclic triterpenic acid (solubilization of pentacyclic triterpenic acids)[9] WO 2017\/021247 A1. Anti-hair loss lotion (hair-care composition containing oleanolic acid blends)[10] CN 103221028 B. Oleanolic acid liposome composition (collagen direction)[11] CN 103648502 B. Anti-inflammatory use of oleanolic acid acetate[12] Attached technical documentation: 28-day human efficacy test of an oleanolic acid-containing blend (gloss \/ pores \/ sebum flow, n\u224820)<\/p>\n

    Disclaimer<\/h3>\n

    This material is prepared by PuriPharm Co., Ltd. for cosmetic ingredient technical exchange only and constitutes no pharmaceutical or medical claims. In-vitro \/ animal study data do not represent finished-product human efficacy; third-party literature and patent data are cited as technical background only. Customers should independently verify the suitability and regulatory compliance of their finished formulations. PuriActives\u00ae and OleaXin™ are trademarks of PuriPharm Co., Ltd.<\/p>\n

    PuriPharm Co., Ltd. \u00b7 www.puriactives.com \u00b7 service@puripharm.com<\/p>\n","protected":false},"excerpt":{"rendered":"

      PURIPHARM CO., LTD. \u00b7 PuriActives\u00ae High-Performa […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[25],"tags":[35,27],"_links":{"self":[{"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/posts\/1409"}],"collection":[{"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1409"}],"version-history":[{"count":1,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/posts\/1409\/revisions"}],"predecessor-version":[{"id":1410,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/posts\/1409\/revisions\/1410"}],"wp:attachment":[{"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1409"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}